|
Market Closed -
London S.E.
11:35:27 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 68.50 GBX | +2.70% |
|
+3.47% | +3.79% |
| 08-20 | Venture Life starts GBP2.6 million additional share buyback | AN |
| 08-20 | Venture Life Extends Share Buyback Program | MT |
| Market Cap | 82.15M 111M 95.72M 90.63M 154M 10.61B 155M 1.08B 414M 5.4B 417M 408M 17.06B | P/E 2026 * |
-29.8x | P/E 2027 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 47.45M 64.17M 55.29M 52.35M 89.02M 6.13B 89.47M 622M 239M 3.12B 241M 236M 9.85B | EV / Sales 2026 * |
0.94x | EV / Sales 2027 * | 1.13x |
| Free-Float |
82.75% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| VLG | Delayed | |
Deutsche Boerse AG
| 17V | Delayed | |
Börse Stuttgart
| 17V | Delayed |
Last Transcript : Venture Life Group plc
| 25-08-05 | Venture Life : Result of General Meeting | PU |
| 25-07-16 | Venture Life : Notice of General Meeting | PU |
| 25-06-30 | Venture Life : 2025 AGM Results | PU |
| 25-06-06 | Venture Life : 2025 Notice of AGM | PU |
| 24-06-04 | Venture Life : 2024 AGM Results | PU |
| 1 day | +2.70% | ||
| 1 week | +3.47% | ||
| Current month | +4.58% | ||
| 3 months | +2.24% | ||
| 6 months | -0.36% | ||
| Current year | +3.79% |
| 1 week | 65.4 | 69 | |
| 1 month | 63.26 | 69 | |
| Current year | 54 | 72 | |
| 1 year | 52 | 72 | |
| 3 years | 27 | 72 | |
| 5 years | 23 | 72 | |
| 10 years | 20 | 118 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeremy Randall
CEO | Chief Executive Officer | 62 | 2010-02-28 |
Daniel Wells
DFI | Director of Finance/CFO | 39 | 2021-11-30 |
Peter Jackson
CTO | Chief Tech/Sci/R&D Officer | - | 2025-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeremy Randall
BRD | Director/Board Member | 62 | 2005-12-11 |
Carl Dempsey
BRD | Director/Board Member | - | 2018-09-19 |
Daniel Wells
BRD | Director/Board Member | 39 | 2021-12-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/3/26 | Buy | Chairman | 8,105 | 0.0067% | ||
| 6/3/26 | Buy | Chairman | 8,066 | 0.0066% | ||
| 6/3/26 | Buy | Chairman | 48,373 | 0.0397% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.70% | +3.47% | +16.10% | +106.02% | 111M | ||
| -0.65% | -2.93% | +47.52% | +87.34% | 994B | ||
| -0.29% | -3.51% | +48.78% | +63.27% | 640B | ||
| +0.83% | +0.26% | +16.76% | +72.52% | 454B | ||
| -0.38% | -3.59% | +28.24% | +35.57% | 337B | ||
| -0.09% | -13.54% | +10.08% | +26.87% | 261B | ||
| -0.43% | -2.48% | -2.07% | +11.48% | 246B | ||
| -1.34% | -13.70% | +33.47% | +44.18% | 204B | ||
| -3.44% | -7.51% | -20.08% | -59.58% | 190B | ||
| -0.75% | -4.82% | +21.94% | +86.55% | 178B | ||
| Average | -0.39% | -4.83% | +20.07% | +47.42% | 350.49B | |
| Weighted average by Cap. | -0.51% | -4.42% | +29.87% | +55.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.35M 68.09M 58.67M 55.55M 94.46M 6.51B 94.94M 660M 254M 3.31B 256M 250M 10.46B | 54.7M 73.97M 63.73M 60.35M 103M 7.07B 103M 717M 276M 3.6B 278M 272M 11.36B |
| Net income | -3.21M -4.35M -3.74M -3.54M -6.03M -415M -6.06M -42.1M -16.19M -211M -16.32M -15.96M -667M | 5.3M 7.16M 6.17M 5.84M 9.93M 684M 9.98M 69.38M 26.68M 348M 26.89M 26.3M 1.1B |
| Net Debt | -34.7M -46.93M -40.43M -38.28M -65.1M -4.48B -65.43M -455M -175M -2.28B -176M -172M -7.21B | -20.2M -27.32M -23.54M -22.29M -37.9M -2.61B -38.09M -265M -102M -1.33B -103M -100M -4.2B |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | GBX 68.50 | +2.70% | 117,176 |
| 26-09-10 | GBX 66.70 | +0.30% | 67,025 |
| 26-09-09 | GBX 66.50 | 0.00% | 39,716 |
| 26-09-08 | GBX 66.50 | 0.00% | 56,107 |
| 26-09-07 | GBX 66.50 | +0.45% | 95,472 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.6850GBP
Average target price
1.500GBP
Spread / Average Target
+118.98%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VLG Stock
Select your edition
All financial news and data tailored to specific country editions

















